VJHemOnc is committed to improving our service to you

ERIC 2020 | The future of CLL treatment: chemotherapy and targeted inhibitors

VJHemOnc is committed to improving our service to you

Catherine Wu

Catherine Wu, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the future of treatment in chronic lymphocytic leukemia (CLL). In the past chemotherapy and individual target inhibitors have been explored. Now the combination of both is being investigated for effect tumour eliminating therapies with limited toxicity. This interview took place during the European Research Initiative on CLL (ERIC) International Virtual Meeting 2020.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter